NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
2 | 2D 1H-13C HSQC | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
3 | 3D HNCO | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
4 | 3D CBCA(CO)NH | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
5 | 3D HNCACB | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
6 | 3D 1H-13C arom NOESY | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
7 | 3D 1H-13C NOESY aliphatic | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
8 | 3D HNCA | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
9 | 3D HN(CO)CA | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
10 | 3D HCCH-TOCSY | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
11 | 2D 1H-15N HSQC | 0.83 mM [U-5% 13C; U-100% 15N] CgR160.0035, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
12 | 2D 1H-13C HSQC aliphatic | 0.83 mM [U-5% 13C; U-100% 15N] CgR160.0035, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
13 | 3D 1H-15N NOESY | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
14 | 4D CC-NOESY | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
15 | 3D HCCH-TOCSY | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
16 | 2D 1H-15N HSQC-Histidine | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
17 | 2D 1H-15N HSQC NH2 only | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
18 | 3D HBHA(CO)NH | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |
19 | 3D HCCH-COSY | 0.76 mM [U-100% 13C; U-100% 15N] CgR160.003, 0.02 % NaN3, 10 mM DTT, 5 mM CaCL2, 100 mM NaCL, 1 x Proteinase Inhibitors, 20 mM MES pH 6.5, 10 % D2O, 50 uM DSS | 90% H2O/10% D2O | | 6.5 | ambient | 298 | |